Limitations of the study are the lack of information on Ki-67, needed for more accurate subdivision of different breast cancer subtypes, and the low number of patients with severe obesity (leading to limited statistical power in particular regarding the subgroup analyses with respect to the four tumor subtypes). Here, MKI67 is linked to obesity due to melanocortin 4 receptor deficiency.